Global HPV Associated Disorders Market Overview Covering Forecast Market Size And Growth Rate 2033 | AstraZeneca plc, F. Hoffmann-La Roche Ltd, Biocon Ltd, GlaxoSmithKline plc, Merck & Co Inc

"The new report published by The Business Research Company, titled ""HPV Associated Disorders Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the hpv associated disorders market size has grown strongly in recent years. It will grow from $19.42 billion in 2023 to $20.97 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The hpv associated disorders market size is expected to see strong growth in the next few years. It will grow to $27.82 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=7777&type=smp

Rising Prevalence Of Hpv-Associated Cases To Drive Hpv Associated Disorders Market
Increased prevalence of HPV-related cases is expected to propel the HPV-associated disorders market. HPV-associated disorders include benign verrucae vulgates, condylomas acuminata to the malignancies of the cervix, anus, and anogenital warts, recurrent respiratory papillomatosis, anogenital and oropharyngeal cancers. HPV infection has a considerable proportion worldwide, mainly in women. For instance, in January 2022, according to a report published by cancer.net, an estimated 14,100 women in the United States will be diagnosed with invasive cervical cancer, with 604,127 women worldwide diagnosed with cervical cancer in 2020. Furthermore, in 2023, an estimated 4,310 deaths occurred from cervical cancer in the United States. Therefore, an increase in the prevalence of HPV cases will drive the HPV-associated disorders market growth.

Emerging Targeted Therapies Revolutionize Treatment Of Hpv Associated Disorders
Targeted therapies are a key trend gaining popularity in HPV-associated disorders. Major players are developing and adopting targeted therapies for treating HPV-associated disorders such as cervical cancer, oropharyngeal cancer, and others. Targeted therapies include drugs that target vascular endothelial growth factor protein and tissue-factor (TF) protein in cancer cells and others. For instance, in September 2021, FDA approved Genmab A/S and Seagen Inc., drug Tivdak (tisotumab vedotin-tftv) for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Thus, emerging targeted therapies will treat HPV-associated disorders effectively.

The hpv associated disorders market covered in this report is segmented -

1) By Indication: Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications
2) By Therapy: Prevention, Treatment
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=7777&type=discount

Major companies operating in the hpv associated disorders market report are AstraZeneca plc, F. Hoffmann-La Roche Ltd, Biocon Ltd, GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Eli Lilly and Company, Sanofi S. A., Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Celgene Corporation, Gilead Sciences Inc., Ipsen S. A., Mylan N. V., Teva Pharmaceutical Industries Ltd., Bayer AG, Eisai Co. Ltd., Genentech Inc., Medtronic plc, Novo Nordisk A/S, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CSL Limited, Lupin Limited

Contents of the report:
1. Executive Summary
2. HPV Associated Disorders Market Report Structure
3. HPV Associated Disorders Market Trends And Strategies
4. HPV Associated Disorders Market - Macro Economic Scenario
5. HPV Associated Disorders Market Size And Growth
…..
27. HPV Associated Disorders Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.